Clinical Trials Logo

Toxemia clinical trials

View clinical trials related to Toxemia.

Filter by:

NCT ID: NCT01724463 Recruiting - Sepsis Clinical Trials

Electronic Application of a Severe Sepsis Screening Tool and Management Bundle

eASSIST-M
Start date: March 2013
Phase: N/A
Study type: Observational

Thousands of children die from Sepsis following routine infections. Many of these deaths can be prevented with earlier recognition and focused management. No tools are currently available to recognize the signs of early sepsis in children. The investigators have developed a electronic health record-based tool that will recognize children with sepsis early and trigger an alert to their hospital caregivers. The caregivers will be prompted to launch a focused management bundle that can stabilize these children, prevent further deterioration and reduce their chances of sepsis related complications and death. The proposed study will test the validity and effectiveness of this electronic tool in reducing sepsis mortality rates.

NCT ID: NCT01694147 Recruiting - Clinical trials for Sepsis Related Acute Lung Injury/Acute Respiratory Distress Syndrome

EVLWI Exhibits Pulmonary and Systemic Permeability in Sepsis Related ALI/ARDS

Start date: July 2011
Phase: N/A
Study type: Observational

To investigate the possible mechanisms of pulmonary and systemic permeability change including cytokine, extravascular lung water index (EVLWI), and oxygenation parameters in patients with sepsis related acute lung injury (ALI)/acute respiratory distress syndrome (ARDS).

NCT ID: NCT01670383 Recruiting - Sepsis Clinical Trials

Repository for Sepsis and Postresuscitation Samples

Start date: July 2006
Phase:
Study type: Observational

The objective of this study is to find a new therapeutic strategy by investigating the serial serum samples of patients with sepsis or postresuscitation state.

NCT ID: NCT01493492 Recruiting - Sepsis Clinical Trials

Urinary Proteomics Analysis for Sepsis and Prognosis

Start date: May 2010
Phase: N/A
Study type: Observational

As a noninvasive examination, urinary proteomics is a very useful tool to identify renal disease. The purpose of the present study was to find differential proteins among patient with SIRS and sepsis(included survivors and non-survivors), and to screen potential biomarkers for the early diagnosis of sepsis and its prognosis. Urinary proteins were identified by iTRAQ labeling and LC-MS/MS. The bioinformatics analysis was performed with the Mascot software and the International Protein Index (IPI) and the Gene Ontology (GO) Database and KEGG pathway Database. The differentially expressed proteins were verified by Western blot by another sample collected from clinical.

NCT ID: NCT01493466 Recruiting - Sepsis Clinical Trials

Serum Proteomics Analysis for Sepsis

Start date: May 2010
Phase: N/A
Study type: Observational

Serum proteomics is a very useful tool to identify various disease. The purpose of the present study was to find differential proteins among patient with normal, SIRS, sepsis, severe sepsis, death and to screen potential biomarkers for their dynamic changes. Serum proteins were identified by iTRAQ labeling and LC-MS/MS. The bioinformatics analysis was performed with the Mascot software and the International Protein Index (IPI) and the Gene Ontology (GO) Database and KEGG pathway Database. The differentially expressed proteins were verified by Western blot by another sample collected from clinical.

NCT ID: NCT01459822 Recruiting - Sepsis Clinical Trials

MiRNAs Evaluate the Prognosis of Sepsis by Dynamic Study

METPSDS
Start date: August 2011
Phase: N/A
Study type: Observational

Sepsis is a common cause of death in intensive care unit, timely and accurate diagnosis and treatment directly affect the survival rate. MiRNA is a post-transcriptional small RNA which regulate mRNA expression. The present study was designed to observe the selected miRNA expression which evaluate the sepsis prognosis in the progression of sepsis in order to be a new target for the treatment of sepsis.

NCT ID: NCT01315782 Recruiting - Sepsis Clinical Trials

Alveolar Dead Space as Predictor of Organ Failure in Severe Sepsis

Start date: December 2016
Phase:
Study type: Observational

This is an observational study to understand the changes in alveolar dead space in medical critically ill patients with severe infection (severe sepsis) requiring mechanical ventilation and the possibility to predict multi-organ failure. The measurement of alveolar dead space used to require sophisticated equipment and time. New ventilators have microprocessors that allow rapid mathematical calculation with minimal intervention.

NCT ID: NCT01255202 Recruiting - Clinical trials for Preeclampsia/Toxemia

The Prediction of Preeclampsia/Toxemia in Twin Pregnancy

Start date: September 2009
Phase: N/A
Study type: Observational

The purpose of this study is to finout whetere uterinae artery flow , PP13 and endogolin levels in the serum and kongo red in the urine can predict preeclamsia toxemia in twin pregnancies.

NCT ID: NCT01207531 Recruiting - Sepsis Clinical Trials

MiRNAs Evaluate the Prognosis of Sepsis

METPS
Start date: July 2010
Phase: N/A
Study type: Observational

Sepsis is a common cause of death in intensive care unit, timely and accurate diagnosis and treatment directly affect the survival rate. MiRNA is a post-transcriptional small RNA which regulate mRNA expression. The present study was designed to screen several miRNA by microarray which evaluate the sepsis prognosis in order to be a new target for the treatment of sepsis.

NCT ID: NCT01169168 Recruiting - Sepsis Clinical Trials

Measurement of Fibrinogen in Patients With Systemic Inflammatory Response Syndrome (SIRS), Sepsis or Chronicle Liver Disease on Intensive Care Units (ICU)

Start date: April 2010
Phase: N/A
Study type: Observational

In this study patients with 1. chronicle liver diseases - primary biliary cirrhosis - primary sclerosing cholangitis - alcoholic liver cirrhosis - hepatitis b or C - Wilson's disease - cryptogenic cirrhosis 2. Septic Inflammatory Response Syndrome (SIRS) - sepsis - septic shock 3. patients after lysis should be included Blood samples will be gathered from the patients to measure fibrinogen with 5 different methods. The methods are: - Clauss fibrinogen - PT-Derived fibrinogen - immunoturbidimetric method - heat-precipitated fibrinogen - Schulz fibrinogen The result of these tests will be correlated with laboratory values which are gathered in routine and the clinical outcomes.